Wuhan High Myopia Study

Launched by RENMIN HOSPITAL OF WUHAN UNIVERSITY · Dec 1, 2023

Keywords

ClinConnect Summary

The Wuhan High Myopia Study is a clinical trial designed to understand how high myopia, a condition where the eye is elongated, affects vision and the structure of the eye over time. The goal is to gather information that can help improve the prevention, diagnosis, and treatment of high myopia, which can lead to serious eye problems if not managed properly.

To participate in this study, individuals must be at least 18 years old and have specific eye measurements indicating high myopia, such as a certain degree of nearsightedness or eye length. Participants will need to agree to follow the study procedures and provide consent. Throughout the trial, they can expect to undergo eye examinations to monitor changes in their vision and eye health. It's important to note that people with certain other eye conditions or those who cannot cooperate with the study procedures will not be eligible to join. If you're interested and meet the criteria, this study could contribute valuable insight into managing high myopia effectively.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Voluntarily sign informed consent;
• • Commit to follow the research procedures and cooperate with the whole process of the study;
• • Age ≥18 years old;
• • Best corrected visual acuity ≥0.1;
• • Spherical Equivalent Refraction≤-6.00D or axial length ≥26mm in high myopia group；
• Exclusion Criteria:
• • Unable or unwilling to sign informed consent;
• • Unable to cooperate with the examination;
• • Astigmatism ≤-1.5D；
• • Patients with refractive interstitial opacity so that fundus images cannot be collected；
• • Patients with fundus diseases such as diabetic retinopathy, hypertensive retinopathy, age-related macular degeneration, retinal vein obstruction, retinal artery obstruction, etc